David L. Andrews

Array ( [id] => 13000167 [patent_doc_number] => 10023743 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-17 [patent_title] => Dichroic pigment compounds and compositions containing the same [patent_app_type] => utility [patent_app_number] => 15/551305 [patent_app_country] => US [patent_app_date] => 2016-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 18941 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 305 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15551305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12185371 [patent_doc_number] => 20180044306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-15 [patent_title] => '1,3,4-THIADIAZOL-2-YL-BENZAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALLING PATHWAY' [patent_app_type] => utility [patent_app_number] => 15/552249 [patent_app_country] => US [patent_app_date] => 2016-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32193 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15552249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11895101 [patent_doc_number] => 09765025 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-19 [patent_title] => 'Method for producing pyrrole derivative, and intermediate thereof' [patent_app_type] => utility [patent_app_number] => 15/043260 [patent_app_country] => US [patent_app_date] => 2016-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9770 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15043260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12178621 [patent_doc_number] => 20180037558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-08 [patent_title] => 'SYNTHESIS OF SULFUR CONTAINING AMMONIUM AND PHOSPHONIUM BORATES' [patent_app_type] => utility [patent_app_number] => 15/549409 [patent_app_country] => US [patent_app_date] => 2016-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7877 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15549409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14422401 [patent_doc_number] => 10315990 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-11 [patent_title] => Isothiocyanate compounds and isothiocyanate XPO1 protein inhibitor drugs thereof [patent_app_type] => utility [patent_app_number] => 15/550783 [patent_app_country] => US [patent_app_date] => 2016-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 9400 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11642126 [patent_doc_number] => 09663482 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-30 [patent_title] => 'Substituted piperazinyl acetohydrazide procaspase-activating compounds' [patent_app_type] => utility [patent_app_number] => 15/013667 [patent_app_country] => US [patent_app_date] => 2016-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 31802 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15013667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12138163 [patent_doc_number] => 20180016246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-18 [patent_title] => 'PROCESS FOR PREPARATION OF POLYMORPHIC FORM OF MIRABEGRON' [patent_app_type] => utility [patent_app_number] => 15/547835 [patent_app_country] => US [patent_app_date] => 2016-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4010 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15547835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11561614 [patent_doc_number] => 09624185 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2017-04-18 [patent_title] => 'Method for preparing IDO inhibitor epacadostat' [patent_app_type] => utility [patent_app_number] => 15/001484 [patent_app_country] => US [patent_app_date] => 2016-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6375 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15001484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13763285 [patent_doc_number] => 10173977 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-08 [patent_title] => 5-aryl-1H-pyrrole-3-carbonitrile and a pharmaceutical product using the same [patent_app_type] => utility [patent_app_number] => 14/994360 [patent_app_country] => US [patent_app_date] => 2016-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29052 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14994360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12259324 [patent_doc_number] => 20180078520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-22 [patent_title] => 'COMPOSITIONS FOR PREVENTION/PROPHYLACTIC TREATMENT OF POISON IVY DERMATITIS' [patent_app_type] => utility [patent_app_number] => 15/563597 [patent_app_country] => US [patent_app_date] => 2016-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 13612 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15563597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10791870 [patent_doc_number] => 20160138026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-19 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF VprBP-RELATED CANCERS' [patent_app_type] => utility [patent_app_number] => 14/992994 [patent_app_country] => US [patent_app_date] => 2016-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 24386 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14992994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12126204 [patent_doc_number] => 20180009790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-11 [patent_title] => 'AN IMPROVED PROCESS FOR THE PREPARATION OF HCV INHIBITOR' [patent_app_type] => utility [patent_app_number] => 15/532515 [patent_app_country] => US [patent_app_date] => 2015-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6087 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15532515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13717009 [patent_doc_number] => 20170369459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-28 [patent_title] => THIADIAZOLYL - OXIMINOACETIC ACID DERIVATIVE COMPOUNDS [patent_app_type] => utility [patent_app_number] => 15/536545 [patent_app_country] => US [patent_app_date] => 2015-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25764 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15536545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10755910 [patent_doc_number] => 20160102062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-14 [patent_title] => 'N-Oxide of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1--1-methyl-urea' [patent_app_type] => utility [patent_app_number] => 14/971412 [patent_app_country] => US [patent_app_date] => 2015-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5045 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14971412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10737256 [patent_doc_number] => 20160083406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-24 [patent_title] => 'EXTRACTION SOLVENT CONTROL FOR REDUCING STABLE EMULSIONS' [patent_app_type] => utility [patent_app_number] => 14/962095 [patent_app_country] => US [patent_app_date] => 2015-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13341 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14962095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14087861 [patent_doc_number] => 10239820 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-26 [patent_title] => Etheramine compounds [patent_app_type] => utility [patent_app_number] => 15/523418 [patent_app_country] => US [patent_app_date] => 2015-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2248 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15523418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10813681 [patent_doc_number] => 20160159840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-09 [patent_title] => 'BISPHOSPHITES HAVING AN UNSYMMETRIC OUTER BIPHENOL UNIT' [patent_app_type] => utility [patent_app_number] => 14/954339 [patent_app_country] => US [patent_app_date] => 2015-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6613 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14954339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10791509 [patent_doc_number] => 20160137665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-19 [patent_title] => 'COMPOSITIONS COMPRISING THIENOPYRIMIDINE AND THIENOPYRIDINE COMPOUNDS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/937421 [patent_app_country] => US [patent_app_date] => 2015-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 31942 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14937421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10706716 [patent_doc_number] => 20160052863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-25 [patent_title] => 'PROCESS FOR PRODUCING AN AMINOPROPYNE OR ENAMINONE' [patent_app_type] => utility [patent_app_number] => 14/932724 [patent_app_country] => US [patent_app_date] => 2015-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9092 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14932724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12092453 [patent_doc_number] => 20170349546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-07 [patent_title] => 'Light-Activated Two-Component Protein Binding Matrix' [patent_app_type] => utility [patent_app_number] => 15/521048 [patent_app_country] => US [patent_app_date] => 2015-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8164 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15521048 [rel_patent_id] =>[rel_patent_doc_number] =>)